The Health-Related Quality of Life of the Patients With Symptomatic Convergence Insufficiency
1 other identifier
observational
300
1 country
1
Brief Summary
This trial is an observational cohort study. Patients aged 8-15 years with symptomatic convergence insufficiency and 150 patients with symptomatic convergence insufficiency who had not received visual training were selected from the Tianjin Eye Hospital Optometry Center and received 1 course of visual training treatment. Self-assessment and other assessments were combined, and the patient and guardian questionnaires were collected. The EQ-5D-Y and CHU9D scales were used to evaluate Chinese patients' health-related quality of life with symptomatic convergence insufficiency. The feasibility of the EQ-5D-Y and CHU9D scales in assessing the health-related quality of life of Chinese patients with symptomatic convergence insufficiency was analyzed. To assess the effectiveness of visual training on visual symptoms and improvement of quality of life in patients with symptomatic convergence insufficiency
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2022
CompletedFirst Submitted
Initial submission to the registry
June 21, 2023
CompletedFirst Posted
Study publicly available on registry
July 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedJuly 17, 2023
June 1, 2023
1.8 years
June 21, 2023
July 13, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Changes in EuroQol five dimensions questionnaire(EQ-5D-5L) score
The EQ-5D-5L questionnaires were used to evaluate the quality of life scores of myopic patients.The health utility value can be calculated by the number of the answer to the question. 0 means death and 1 means complete health.
The changes between baseline and 3 months
Changes in shortForm 6D(SF-6D) questionnaire score
The SF-6D questionnaires were used to evaluate the quality of life scores of myopic patients.The health utility value can be calculated by the number of the answer to the question. 0 means death and 1 means complete health.
The changes between baseline and 3 months
Study Arms (2)
Training group
Patients with symptomatic convergence insufficiency who had received visual training
Not training group
Patients with symptomatic convergence insufficiency who had not received visual training
Interventions
Completion of 1 session of standardized visual training
Eligibility Criteria
Adolescent patients with insufficient astringency
You may qualify if:
- \~15 years old
- Monocular best corrected visual acuity at distance and near was more than 0.8
- Near exophoria 4Δ greater than distance exophoria
- NPC ≥ 6cm
- PFV ≤15△BO
- Stereogram ≤500 ''
- Score of CISS questionnaire ≥16 or COVD questionnaire≥20
You may not qualify if:
- present constant strabismus, nystagmus or vertical phoria at distance or near.
- developmental delay or ocular surgery
- Myopia≤ -6.00D, Hyperopia ≥ +5.00D, Astigmatism ≥ 4.00D
- Monocular Amplitude of accommodation\<5D
- Other diseases except myopia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tianjin Eye Hospital
Tianjin, 300020, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2023
First Posted
July 17, 2023
Study Start
June 1, 2022
Primary Completion
April 1, 2024
Study Completion
June 30, 2024
Last Updated
July 17, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share